Approved Biologic Therapies In Rheumatoid Arthritis Show Further Evidence Of Efficacy And Reduction In Joint Damage

One of the major annual rheumatology conferences, the European League Against Rheumatism's Congress (EULAR), was held May 25-28 in London. Citeline, Inc., reviewed the trends and highlights from clinical trial results reported at EULAR, noting that approved biologics in rheumatoid arthritis dominated the program, comprising roughly 25% of clinical trial abstracts presented...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/E7nnCgG39i4/228076.php

medical rehab sport